Deswal A - Search Results

1

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

Ather S, Peterson LE, Divakaran VG, Deswal A, Ramasubbu K, Giorgberidze I, Blaustein A, Wehrens XH, Mann DL, Bozkurt B. Ather S, et al. Among authors: deswal a. Int J Cardiol. 2011 Aug 4;150(3):264-9. doi: 10.1016/j.ijcard.2010.04.021. Epub 2010 May 15. Int J Cardiol. 2011. PMID: 20471706 Free PMC article. Clinical Trial.

2

The role of cytokines in disease progression in heart failure.

Shan K, Kurrelmeyer K, Seta Y, Wang F, Dibbs Z, Deswal A, Lee-Jackson D, Mann DL. Shan K, et al. Among authors: deswal a. Curr Opin Cardiol. 1997 May;12(3):218-23. doi: 10.1097/00001573-199705000-00002. Curr Opin Cardiol. 1997. PMID: 9243078 Review.

3

An overview of tumor necrosis factor alpha and the failing human heart.

Torre-Amione G, Bozkurt B, Deswal A, Mann DL. Torre-Amione G, et al. Among authors: deswal a. Curr Opin Cardiol. 1999 May;14(3):206-10. doi: 10.1097/00001573-199905000-00003. Curr Opin Cardiol. 1999. PMID: 10358791 Review.

4

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes FA, Blosch C, Mann DL. Deswal A, et al. Circulation. 1999 Jun 29;99(25):3224-6. doi: 10.1161/01.cir.99.25.3224. Circulation. 1999. PMID: 10385494 Clinical Trial.

5

The role of anti-cytokine therapy in the failing heart.

Deswal A, Misra A, Bozkurt B. Deswal A, et al. Heart Fail Rev. 2001 Mar;6(2):143-51. doi: 10.1023/a:1011462011567. Heart Fail Rev. 2001. PMID: 11309533 Review.

6

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Deswal A, et al. Circulation. 2001 Apr 24;103(16):2055-9. doi: 10.1161/01.cir.103.16.2055. Circulation. 2001. PMID: 11319194

7

Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial.

Deswal A, Petersen NJ, Feldman AM, White BG, Mann DL. Deswal A, et al. Chest. 2001 Aug;120(2):453-9. doi: 10.1378/chest.120.2.453. Chest. 2001. PMID: 11502643 Clinical Trial.

8

New therapeutics for chronic heart failure.

Mann DL, Deswal A, Bozkurt B, Torre-Amione G. Mann DL, et al. Among authors: deswal a. Annu Rev Med. 2002;53:59-74. doi: 10.1146/annurev.med.53.082901.104004. Annu Rev Med. 2002. PMID: 11818463 Review.

9

Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.

Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee-Jackson D, Bozkurt B, Deswal A, Mann DL, Spinale FG. Wilson EM, et al. Among authors: deswal a. J Card Fail. 2002 Dec;8(6):390-8. doi: 10.1054/jcaf.2002.129659. J Card Fail. 2002. PMID: 12528092

10

Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure.

Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL. Malave HA, et al. Among authors: deswal a. Chest. 2003 Mar;123(3):716-24. doi: 10.1378/chest.123.3.716. Chest. 2003. PMID: 12628868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters